| Literature DB >> 27556437 |
Liang Cai1,2, Li-Fang Wang3,4, Jun-Ping Pan5, Xiang-Nan Mi6, Zheng Zhang7, Hai-Ju Geng8, Jia-Hui Wang9, Song-Hui Hu10, Wei Zhang11, Qin Gao12, Wu-Tian Wu13, Huan-Min Luo14,15.
Abstract
This study investigated the neuroprotective effects of methyl 3,4-dihydroxybenzoate (MDHB) against t-butyl hydroperoxide (TBHP) induced oxidative damage in SH-SY5Y (human neuroblastoma cells) and the underlying mechanisms. SH-SY5Y were cultured in DMEM + 10% FBS for 24 h and pretreated with different concentrations of MDHB or N-acetyl-l-cysteine (NAC) for 4 h prior to the addition of 40 μM TBHP for 24 h. Cell viability was analyzed using the methylthiazolyltetrazolium (MTT) and lactate dehydrogenase (LDH) assays. An annexin V-FITC assay was used to detect cell apoptosis rates. The 2',7'-dichlorofluorescin diacetate (DCFH-DA) assay was used to determine intracellular ROS levels. The activities of antioxidative enzymes (GSH-Px and SOD) were measured using commercially available kits. The oxidative DNA damage marker 8-OHdG was detected using ELISA. Western blotting was used to determine the expression of Bcl-2, Bax, caspase 3, p-Akt and Akt proteins in treated SH-SY5Y cells. Our results showed that MDHB is an effective neuroprotective compound that can mitigate oxidative stress and inhibit apoptosis in SH-SY5Y cells.Entities:
Keywords: apoptosis; methyl 3,4-dihydroxybenzoate; neuroprotection; nuclear factor erythroid 2-related factor 2; oxidative stress
Mesh:
Substances:
Year: 2016 PMID: 27556437 PMCID: PMC6274188 DOI: 10.3390/molecules21081071
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1The effect of different concentration of MDHB on TBHP-treated SH-SY5Y cells by MTT assay and LDH assay. (A) The safety margin of MDHB. Cell viability was measured by MTT assay. SH-SY5Y cells were cultured with MDHB at 2~128 μM and 0.1% DMOS for 24 h. Data were normalized by control group. Values represent means ± S.E.M (n = 4); * p < 0.05 versus the TBHP-treated alone group (n = 4); (B) The cells were pretreated with 2, 4, or 8 μM of MDHB for 4 h, followed by treatment with 40 μM TBHP for 24 h. Cell viability was measured using the MTT assay. Data are normalized to the control group. Values represent means ± S.E.M. ## p < 0.01 versus the control group. ** p < 0.01 versus the TBHP-treated alone group (n = 4); (C) Cells were pretreated with 2, 4, or 8 μM of MDHB for 4 h, followed by treatment with 40 μM TBHP for 24 h. LDH release was measured. Data are normalized to the control group. Values represent means ± S.E.M. ## p < 0.01 versus the control group. ** p < 0.01 versus the TBHP-treated alone group (n = 4).
Figure 2Effect of MDHB on TBHP-induced apoptosis in SH-SY5Y cells. (A) Control group; (B) 40 μM THBP group; (C) 2 μM MDHB + TBHP group; (D) 4 μM MDHB + TBHP group; (E) 8 μM MDHB + TBHP group; and (F) 100 μM NAC + TBHP group; The statistical result of annexin V/PI staining (G) showed that MDHB (2, 4, 8μM) can reduce RGC-5 cell apoptosis compared to H2O2-treated cells. Data are expressed as the mean ± S.E.M. ## p < 0.01 versus the control group. ** p < 0.01 versus the TBHP-treated alone group (n = 3).
Figure 3The scavenging rate of MDHB on DPPH free radical. Data are expressed as the mean ± S.E.M.
Figure 4Effect of MDHB on TBHP-induced ROS accumulation in SH-SY5Y cells. SH-SY5Y cells were treated with MDHB (2, 4, or 8 μM) for 4 h before exposure to 40 μM TBHP for another 24 h. Intracellular ROS levels were measured via incubation with DCFH-DA fluorescent dye and analyzed using flow cytometry. (A) Control group; (B) 40 μM THBP group; (C) 2 μM MDHB + TBHP group; (D) 4 μM MDHB + TBHP group; and (E) 8 μM MDHB + TBHP group; The statistical result of DCFH-DA staining (F) showed that MDHB (2, 4, 8 μM) can reduce remarkably TBHP-induced ROS accumulation in SH-SY5Y cells. Values represent the mean ± S.E.M, ## p < 0.01 versus the control group. * p < 0.05 versus the TBHP group. ** p < 0.01 versus the TBHP group (n = 3).
Figure 5(A) Effect of MDHB on intracellular SOD activity in SH-SY5Y cells. SH-SY5Y cells were treated with MDHB (2, 4, or 8 μM) for 4 h before exposure to 40 μM TBHP for another 24 h. Intracellular SOD activity was estimated using WST-1 assay. Data are expressed as the mean ± S.E.M. ## p < 0.01 versus the control group. * p < 0.05 versus the TBHP group (n = 4); (B) Effect of MDHB on intracellular GSH-Px activity in SH-SY5Y cells. Intracellular GSH-Px activity was estimated using a colorimetric assay. The data are expressed as the mean ± S.E.M. ## p < 0.01 versus the control group, ** p < 0.01 versus the TBHP group (n = 3); (C) Effect of MDHB on 8-OHdG levels in the cultured media of SH-SY5Y cells. SH-SY5Y cells were treated with MDHB (2, 4, or 8 μM) for 4 h before exposure to 40 μM TBHP for another 24 h. 8-OHdG levels in the cultured media of SH-SY5Y cells were detected using ELISA. The data are expressed as the mean ± S.EM. ## p < 0.01 versus control group. ** p < 0.01 versus TBHP group (n = 3).
Figure 6Effect of MDHB on Bcl2/Bax, cleaved caspase-3/pro-caspase-3, p-Akt/Akt expression in SH-SY5Y cells. Protein expression was estimated using Western blot. (A) Effect of MDHB on Bcl2/Bax expression in SH-SY5Y cells. The data are expressed as the mean ± S.EM. # p < 0.05 versus the control group. ** p < 0.01 versus the TBHP group (n = 3); (B) Effect of MDHB on the expression of cleaved caspase-3/pro-caspase-3 in SH-SY5Y cells. The data are expressed as the mean ± S.EM. ## p < 0.01 versus the control group. ** p < 0.01 versus the TBHP group (n = 3); (C) Effect of MDHB on p-Akt/Akt expression in SH-SY5Y cells. The data are expressed as the mean ± S.EM. ## p < 0.01 versus control group, * p < 0.05 versus TBHP group (n = 3).